<DOC>
	<DOC>NCT00618176</DOC>
	<brief_summary>The purpose of this study is to determine whether the three generic nevirapine-based antiretroviral regimens are effective in the treatment of Acquired immune deficiency syndrome .</brief_summary>
	<brief_title>Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>18 years or older the subjects were HIVseropositive by standard serum enzymelinked immunosorbent assay (ELISA) tests and also by Western blot analysis the subjects were antiretroviral drugnaïve a baseline CD4+ Tcell count from 100 to 350 cells/mm3 and a baseline plasma viral load over 500copies/ml pregnancy or breastfeeding anticipated nonadherence AIDSdefining illness within 2 weeks of entry white blood cell count less than 2.0×109/L, absolute neutrophil count less than 1.0×109/L, hemoglobin level less than 90g/l, platelet count less than 0.75×1012/L transaminase and alkaline phosphatase level more than 3 times the upper limit of the normal range, bilirubin level more than 2.5times the upper limit of the normal range, serum creatinine level more than 1.5 times the upper limit of the normal range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>adverse effects</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Drug Resistance, Viral</keyword>
	<keyword>treatment naïve</keyword>
</DOC>